Hypothesis 3: HepaCAM-Containing Extracellular Vesicles

Target: HEPACAM1, HEPACAM2 Composite Score: 0.762 Price: $0.75▲0.4% Citation Quality: Pending neurodegeneration Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

✓ All Quality Gates Passed

Quality Report Card click to collapse

B+

Composite: 0.762

Top 21% of 685 hypotheses

T5 Contested

Contradicted by evidence, under dispute

C+ Mech. Plausibility 15% 0.55 Top 75%

C Evidence Strength 15% 0.48 Top 79%

B+ Novelty 12% 0.72 Top 64%

D Feasibility 12% 0.35 Top 83%

C+ Impact 12% 0.50 Top 87%

D Druggability 10% 0.28 Top 90%

C Safety Profile 8% 0.40 Top 79%

D Competition 6% 0.30 Top 96%

C+ Data Availability 5% 0.52 Top 70%

C Reproducibility 5% 0.45 Top 79%

Evidence

3 supporting | 8 opposing

Citation quality: 0%

Debates

0 sessions

No debates yet

Convergence

0.00 F 30 related hypothesis share this target

Hypotheses from Same Analysis (4)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome

Score: 0.971 | Target: SST, SSTR1, SSTR2

Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse

Score: 0.889 | Target: SLC16A1, SLC16A7, LDHA, PDHA1

Hypothesis 1: MANF/CDNF Signaling as Primary Neuroprotective Effector

Score: 0.818 | Target: MANF, CDNF

Hypothesis 2: GPNMB-CD44 Axis as Anti-inflammatory Pathway

Score: 0.772 | Target: GPNMB, CD44

Description

Healthy astrocytes secrete neuroprotective factors via extracellular vesicles (EVs), with HepaCAM representing a critical EV cargo protecting against excitotoxic motor neuron death. Inflammatory cytokines disrupt astrocyte exosomal HepaCAM packaging, releasing EVs that instead promote neuronal vulnerability.

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

11 citations 11 with PMID Validation: 0% 3 supporting / 8 opposing

✓ For (3)

No supporting evidence

No opposing evidence

(8) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 10CLIN 1GENE 0EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
Inflammatory cytokines disrupt astrocyte exosomal …	Supporting	MECH	-	-	-	-	PMID:39602529	-
Astrocyte-derived extracellular vesicles induce mo…	Supporting	MECH	-	-	-	-	PMID:37644868	-
Regional astrocyte diversity in ALS includes disti…	Supporting	MECH	-	-	-	-	PMID:32739211	-
Astrocyte EVs can be toxic via miRNA-155-5p; contr…	Opposing	MECH	-	-	-	-	PMID:37644868	-
HepaCAM is a cell adhesion molecule with predomina…	Opposing	MECH	-	-	-	-	PMID:39602529	-
Codiak BioSciences (engineered exosomes) failed 20…	Opposing	MECH	-	-	-	-	PMID:CODIAK_FAILURE	-
EV protection may be non-specific; total EV protei…	Opposing	MECH	-	-	-	-	PMID:32739211	-
Purifying HepaCAM+ EVs specifically from total EVs…	Opposing	MECH	-	-	-	-	PMID:37644868	-
Causality not established: HepaCAM necessary/suffi…	Opposing	MECH	-	-	-	-	PMID:39602529	-
Manufacturing challenges: estimated $50,000-100,00…	Opposing	CLIN	-	-	-	-	PMID:CODIAK_FAILURE	-
EVs don't readily cross blood-brain barrier; …	Opposing	MECH	-	-	-	-	PMID:CODIAK_FAILURE	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 3

Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity …▼

Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in SOD1G93A ALS model

PMID:39602529

Astrocyte-derived extracellular vesicles induce motor neuron death via miRNA-155-5p in SOD1(G93A) model - demo…▼

Astrocyte-derived extracellular vesicles induce motor neuron death via miRNA-155-5p in SOD1(G93A) model - demonstrates EV-mediated astrocyte-motor neuron communication

PMID:37644868

Regional astrocyte diversity in ALS includes distinct aberrant phenotypes affecting EV cargo

PMID:32739211

✗ Opposing Evidence 8

Astrocyte EVs can be toxic via miRNA-155-5p; contradicts protective EV hypothesis

PMID:37644868

HepaCAM is a cell adhesion molecule with predominant expression in liver and brain; mechanism of EV packaging …▼

HepaCAM is a cell adhesion molecule with predominant expression in liver and brain; mechanism of EV packaging unexplained

PMID:39602529

Codiak BioSciences (engineered exosomes) failed 2023 indicating sector challenges

PMID:CODIAK_FAILURE

EV protection may be non-specific; total EV protein content may mediate effects rather than single cargo

PMID:32739211

Purifying HepaCAM+ EVs specifically from total EVs is technically challenging and may not yield pure protectiv…▼

Purifying HepaCAM+ EVs specifically from total EVs is technically challenging and may not yield pure protective preparations

PMID:37644868

Causality not established: HepaCAM necessary/sufficient for protection not demonstrated

PMID:39602529

Manufacturing challenges: estimated $50,000-100,000 per patient-year for autologous EV therapy

PMID:CODIAK_FAILURE

EVs don't readily cross blood-brain barrier; targeting to motor neurons not demonstrated

PMID:CODIAK_FAILURE

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.

Price History

7d Trend

↔

Stable

7d Momentum

▲ 0.4%

Volatility

Low

0.0040

Events (7d)

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (4)

Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model.

Science advances (2024) · PMID:39602529

7 figures

Fig. 1.

Proinflammatory cytokines reduce secretion of A-Exo. and in vivo spreading along spinal cords of SOD1G93A mice. ( A ) Representative immunoEM images of mouse (m)CD63 labeling in A-...

pmc_api

Fig. 2.

Misfolded SOD1 proteins are minimally associated with SOD1G93A A-Exo. and N-Exo. in vitro and in vivo. ( A ) Representative immunoblots of hSOD1G93A and misfolded SOD1 in eluted SE...

pmc_api

Astrocyte regional diversity in ALS includes distinct aberrant phenotypes with common and causal pathological processes.

Experimental cell research (2021) · PMID:32739211

No extracted figures yet

SOD1<sup>G93A</sup> Astrocyte-Derived Extracellular Vesicles Induce Motor Neuron Death by a miRNA-155-5p-Mediated Mechanism.

ASN neuro (2023) · PMID:37644868

No extracted figures yet

Paper:CODIAK_FAILURE

No extracted figures yet